Niacin, N-3 Fatty Acids and Insulin Resistance

NCT00286234 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Hypertriglyceridemia

Interventions

DRUG: omega-3 acid ethyl esters
DRUG: extended release niacin
DRUG: placebo
DRUG: omega-3 acid ethyl esters
DRUG: combined treatment

Sponsor

University of South Dakota

Collaborators

[object Object]